Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Colorectal Medullary Carcinoma”

43 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 43 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT02978625
What this trial is testing

Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers

Who this might be right for
Anaplastic Large Cell Lymphoma, ALK-NegativeAnaplastic Large Cell Lymphoma, ALK-PositiveApocrine Carcinoma+36 more
National Cancer Institute (NCI) 68
Testing effectiveness (Phase 2)Active Not RecruitingNCT03157128
What this trial is testing

Selpercatinib (LOXO-292) in Participants With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer (LIBRETTO-001)

Who this might be right for
Non-Small Cell Lung CancerMedullary Thyroid CancerColon Cancer+1 more
Eli Lilly and Company 857
Not applicableStudy completedNCT00132704
What this trial is testing

An Analysis of the Response of Human Tumor Microvascular Endothelium to Ionizing Radiation

Who this might be right for
Ovarian NeoplasmsColorectal NeoplasmsMelanoma+2 more
Memorial Sloan Kettering Cancer Center 149
Testing effectiveness (Phase 2)Looking for participantsNCT07702292
What this trial is testing

[68Ga]BED003 PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications

Who this might be right for
Colorectal CancerEpithelial Ovarian CancerGastric Cancer (GC)+2 more
Blue Earth Diagnostics 71
Testing effectiveness (Phase 2)Study completedNCT00019331
What this trial is testing

Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid Tumors

Who this might be right for
Colorectal CancerEndometrial CancerHead and Neck Cancer+6 more
National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT04045496
What this trial is testing

A First-in-Human, Phase 1 Study of JAB-3312 in Adult Patients With Advanced Solid Tumors

Who this might be right for
Non-small Cell Lung CancerColorectal CancerPancreatic Ductal Carcinoma+4 more
Jacobio Pharmaceuticals Co., Ltd. 40
Early research (Phase 1)Study completedNCT00004604
What this trial is testing

Biological Therapy in Treating Patients With Metastatic Cancer

Who this might be right for
Breast CancerColorectal CancerExtrahepatic Bile Duct Cancer+9 more
Duke University 24
Early research (Phase 1)Study completedNCT00028496
What this trial is testing

Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer

Who this might be right for
Adenocarcinoma of the ColonAdenocarcinoma of the GallbladderAdenocarcinoma of the Pancreas+39 more
National Cancer Institute (NCI) 48
Early research (Phase 1)Looking for participantsNCT07213791
What this trial is testing

LY4337713 in Participants With FAP-Positive Solid Tumors

Who this might be right for
Ovarian NeoplasmsBreast NeoplasmsPancreatic Intraductal Neoplasms+4 more
Eli Lilly and Company 241
Early research (Phase 1)Study completedNCT04121286
What this trial is testing

JAB-3312 in Adult Patients With Advanced Solid Tumors in China

Who this might be right for
Non-small Cell Lung CancerColorectal CancerPancreatic Ductal Carcinoma+4 more
Allist Pharmaceuticals, Inc. 17
Testing effectiveness (Phase 2)Looking for participantsNCT05288205
What this trial is testing

Phase 1/2a Study of JAB-21822 Plus JAB-3312 in Patients With Advanced Solid Tumors Harboring KRAS p.G12C Mutation

Who this might be right for
KRAS P.G12CNon-small Cell Lung CancerColorectal Cancer+1 more
Allist Pharmaceuticals, Inc. 240
Not applicableStudy completedNCT05280379
What this trial is testing

Trained Immunity in Thyroid Carcinoma and Colon Carcinoma

Who this might be right for
Thyroid Cancer, NonmedullaryColon Carcinoma
Radboud University Medical Center 33
Testing effectiveness (Phase 2)Looking for participantsNCT07432633
What this trial is testing

[18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications

Who this might be right for
Colorectal CancerEpithelial Ovarian CancerGastric Cancer+2 more
Blue Earth Diagnostics 71
Early research (Phase 1)Ended earlyNCT06704724
What this trial is testing

Learn About the Study Medicine PF-07985045 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Change in a Gene.

Who this might be right for
Carcinoma, Pancreatic DuctalColorectal NeoplasmsCarcinoma, Non-Small-Cell Lung
Pfizer 30
Testing effectiveness (Phase 2)Looking for participantsNCT06445062
What this trial is testing

Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors

Who this might be right for
Colorectal CancerCRCPancreatic Ductal Adenocarcinoma+3 more
Revolution Medicines, Inc. 1,130
Early research (Phase 1)Active Not RecruitingNCT05462717
What this trial is testing

Dose Escalation and Dose Expansion Study of RMC-6291 Monotherapy in Subjects With Advanced KRASG12C Mutant Solid Tumors

Who this might be right for
Non-Small Cell Lung Cancer (NSCLC)Colorectal Cancer (CRC)Pancreatic Ductal Adenocarcinoma+1 more
Revolution Medicines, Inc. 222
Not applicableStudy completedNCT02933307
What this trial is testing

Continuous Monitoring on the General Ward

Who this might be right for
Carcinoma, Pancreatic DuctalColorectal NeoplasmsArthritis+2 more
Radboud University Medical Center 90
Testing effectiveness (Phase 2)Active Not RecruitingNCT03899792
What this trial is testing

Oral LOXO-292 (Selpercatinib) in Pediatric Participants With Advanced Solid or Primary Central Nervous System (CNS) Tumors

Who this might be right for
Medullary Thyroid CancerInfantile MyofibromatosisInfantile Fibrosarcoma+2 more
Eli Lilly and Company 36
Testing effectiveness (Phase 2)Study completedNCT01040000
What this trial is testing

QUILT-3.019: Phase 2 Study of NPC-1C Chimeric Monoclonal Antibody to Treat Pancreatic and Colorectal Cancer

Who this might be right for
Metastatic Pancreatic CancerMetastatic Colorectal Cancer
Precision Biologics, Inc 94
Not applicableEnded earlyNCT02363647
What this trial is testing

Personalized Cancer Therapy for Patients With Metastatic Medullary Thyroid or Metastatic Colon Cancer

Who this might be right for
Medullary Thyroid CancerColon Cancer
Icahn School of Medicine at Mount Sinai 10
Next Page